Clinical outcomes in COVID-19 patients treated with tocilizumab: An individual patient data systematic review.

D, Antwi-Amoabeng; Z, Kanji; B, Ford; BD, Beutler; MS, Riddle; F, Siddiqui

doi:10.1002/jmv.26038

Public

Clinical outcomes in COVID-19 patients treated with tocilizumab: An individual patient data systematic review.

Shared by NobleBlocks on Jun 9, 2020 • 12:00 AM UTC

Authors:

Antwi-Amoabeng D

Kanji Z

Ford B

Abstract

Background Current evidence suggests an important role of the interleukin-6 (IL-6) pathway in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related cytokine release storm in severely ill coronavirus disease 2019 (COVID-19) patients. Inhibition of the IL-6 pathway with tocilizumab has ...

Subject

Tocilizumab

Individual Patient Data

Anti-interleukin-6 Receptor Antibody

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!